
Конвидеция (ad5-ncov) — участники исследования и обсуждение вакцины
282 Members
Date:
4.6
37036 Reviews
37036 Reviews
34563 Posts
Конвидеция (ad5-ncov) — участники исследования и обсуждение вакцины Telegram | DID YOU KNOW?
Pavel Durov, Telegram's CEO, is known as "the Russian Mark Zuckerberg," for co-founding VKontakte, which is Russian for "in touch," a Facebook imitator that became the country's most popular social networking site. The account, "War on Fakes," was created on February 24, the same day Russian President Vladimir Putin announced a "special military operation" and troops began invading Ukraine. The page is rife with disinformation, according to The Atlantic Council's Digital Forensic Research Lab, which studies digital extremism and published a report examining the channel. Ukrainian forces have since put up a strong resistance to the Russian troops amid the war that has left hundreds of Ukrainian civilians, including children, dead, according to the United Nations. Ukrainian and international officials have accused Russia of targeting civilian populations with shelling and bombardments. Recently, Durav wrote on his Telegram channel that users' right to privacy, in light of the war in Ukraine, is "sacred, now more than ever." On Feb. 27, however, he admitted from his Russian-language account that "Telegram channels are increasingly becoming a source of unverified information related to Ukrainian events."
Конвидеция (ad5-ncov) — участники исследования и обсуждение вакцины from us
Конвидеция (ad5-ncov) — участники исследования и обсуждение вакцины
group-telegram.com/Ad5ncov
Singapore SG telegram Group & telegram Channel 10
Telegram Конвидеция (ad5-ncov) — участники исследования и обсуждение вакцины

Created:
From: Singapore and American
Telegram Конвидеция (ad5-ncov) — участники исследования и обсуждение вакцины, 653268 Telegram Group & Telegram Channel Singapore, SGTelegram Конвидеция (ad5-ncov) — участники исследования и обсуждение вакцины, 653268 Telegram Group & Telegram Channel, American, US
TG ad5-ncov — участники исследования
https://t.me/Ad5ncov